• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RAC

RACE ONCOLOGY LTD - Announcements

0.82% ! $1.22
Market Cap $212.8M  !

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a... Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.More

Corporate Spotlight

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.
View the full Corporate Spotlight arrow Created with Sketch.

RAC Accelerates Game-Changing Cancer Drug

Announcements



Filters [Clear]
  • Price Sensitive: Yes
RAC University of Wollongong R&D CollaborationPRICE SENSITIVE09/11/21 download Created with Sketch. 121.33KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/10/21 download Created with Sketch. 374.46KB
RAC Race secures sixth US patent for ZantrenePRICE SENSITIVE19/10/21 download Created with Sketch. 63.01KB
RAC Race secures fifth US patent for ZantrenePRICE SENSITIVE06/10/21 download Created with Sketch. 60.34KB
RAC Preclinical & Clinical Programs UpdatePRICE SENSITIVE30/09/21 download Created with Sketch. 71.09KB
RAC Zantrene highly effective in Melanoma preclinical studyPRICE SENSITIVE30/09/21 download Created with Sketch. 827.42KB
RAC Appendix 4E & Annual ReportPRICE SENSITIVE26/08/21 download Created with Sketch. 4.99MB
RAC First Patient Dosed in Phase 1b/2 AML TrialPRICE SENSITIVE09/08/21 download Created with Sketch. 117.45KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE29/07/21 download Created with Sketch. 314.92KB
RAC Race executes Israel AML Phase 2 Trial ContractPRICE SENSITIVE22/06/21 download Created with Sketch. 137.91KB
RAC Race Executes Key Contract for Israel Phase 2 AML TrialPRICE SENSITIVE08/06/21 download Created with Sketch. 59.49KB
RAC Contract to Commence Phase 2 Extramedullary AML TrialPRICE SENSITIVE02/06/21 download Created with Sketch. 122.87KB
RAC ProspectusPRICE SENSITIVE05/05/21 download Created with Sketch. 420.89KB
RAC Race investor briefing & updated presentationPRICE SENSITIVE05/05/21 download Created with Sketch. 7.51MB
RAC Placement closes oversubscribed-Bonus Option Issue launchedPRICE SENSITIVE05/05/21 download Created with Sketch. 333.71KB
RAC Trading HaltPRICE SENSITIVE03/05/21 download Created with Sketch. 181.01KB
RAC Race Initiates Heart Safety Preclinical Study for BisantrenePRICE SENSITIVE28/04/21 download Created with Sketch. 313.1KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE27/04/21 download Created with Sketch. 222.27KB
RAC Second independent study shows Bisantrene inhibits FTOPRICE SENSITIVE15/04/21 download Created with Sketch. 106.83KB
RAC Race Strategic Update March 2021PRICE SENSITIVE31/03/21 download Created with Sketch. 248.9KB
RAC Race Initiates Extramedullary AML Preclinical StudyPRICE SENSITIVE30/03/21 download Created with Sketch. 112.93KB
RAC Race Initiates FTO Directed Kidney Cancer Preclinical StudyPRICE SENSITIVE25/03/21 download Created with Sketch. 111.89KB
RAC Race Initiates FTO Melanoma Preclinical StudyPRICE SENSITIVE19/03/21 download Created with Sketch. 114.1KB
RAC S&P DJI Announces March 2021 Quarterly RebalancePRICE SENSITIVE12/03/21 download Created with Sketch. 183.24KB
RAC Compelling Preclinical Breast Cancer ResultsPRICE SENSITIVE09/03/21 download Created with Sketch. 1.27MB
RAC Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE25/02/21 download Created with Sketch. 972.04KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE27/01/21 download Created with Sketch. 242.62KB
RAC Race receives $387k R&D tax incentive refundPRICE SENSITIVE17/12/20 download Created with Sketch. 100.49KB
RAC Race AGM presentations and strategic updatePRICE SENSITIVE30/11/20 download Created with Sketch. 7.11MB
RAC Impressive Preclinical Bisantrene Breast Cancer ResultsPRICE SENSITIVE24/11/20 download Created with Sketch. 1.23MB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE29/10/20 download Created with Sketch. 223.87KB
RAC Prof Borje S Andersson appointed Chief Medical OfficerPRICE SENSITIVE02/10/20 download Created with Sketch. 113.33KB
RAC Race leadership team strengthenedPRICE SENSITIVE02/09/20 download Created with Sketch. 118.79KB
RAC Appendix 4E & Annual ReportPRICE SENSITIVE27/08/20 download Created with Sketch. 1.51MB
RAC Strategic investors make further $1.5m investment in RacePRICE SENSITIVE12/08/20 download Created with Sketch. 107.23KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE29/07/20 download Created with Sketch. 244.83KB
RAC A$3m strategic investment from prominent biotech investorsPRICE SENSITIVE13/07/20 download Created with Sketch. 112.69KB
RAC Trading HaltPRICE SENSITIVE09/07/20 download Created with Sketch. 510.27KB
RAC Extension of time to repay loan through share buy-backPRICE SENSITIVE16/06/20 download Created with Sketch. 93.74KB
RAC Impressive 40% response in Phase II Bisantrene AML TrialPRICE SENSITIVE16/06/20 download Created with Sketch. 203.95KB
RAC Trading HaltPRICE SENSITIVE12/06/20 download Created with Sketch. 496.08KB
RAC Managing Director ResignationPRICE SENSITIVE20/05/20 download Created with Sketch. 120.4KB
RAC Trading HaltPRICE SENSITIVE18/05/20 download Created with Sketch. 175.55KB
RAC Pause in TradingPRICE SENSITIVE18/05/20 download Created with Sketch. 116.72KB
RAC Race starts preclinical breast cancer study for BisantrenePRICE SENSITIVE14/05/20 download Created with Sketch. 131.29KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE22/04/20 download Created with Sketch. 165.75KB
RAC Race Secures A$1.8m strategic placementPRICE SENSITIVE06/03/20 download Created with Sketch. 107.91KB
RAC Trading HaltPRICE SENSITIVE04/03/20 download Created with Sketch. 673.25KB
RAC Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE25/02/20 download Created with Sketch. 923.29KB
RAC December 2019 Quarterly ReportPRICE SENSITIVE30/01/20 download Created with Sketch. 263.65KB
RAC Race Receives $159k R&D Tax Incentive RefundPRICE SENSITIVE16/12/19 download Created with Sketch. 91.29KB
RAC Race reveals new strategy for cancer drug BisantrenePRICE SENSITIVE14/11/19 download Created with Sketch. 3.58MB
RAC Appendix 4C - quarterlyPRICE SENSITIVE17/10/19 download Created with Sketch. 186.66KB
RAC Appendix 4E & Annual ReportPRICE SENSITIVE23/08/19 download Created with Sketch. 1007.27KB
RAC Prominent biotech investor leads investment in RacePRICE SENSITIVE20/08/19 download Created with Sketch. 110.8KB
RAC Trading HaltPRICE SENSITIVE16/08/19 download Created with Sketch. 162.37KB
RAC Appendix 4C - quarterlyPRICE SENSITIVE30/07/19 download Created with Sketch. 108.16KB
RAC First patient treated in Bisantrene trial in IsraelPRICE SENSITIVE25/07/19 download Created with Sketch. 91.73KB
RAC Bisantrene AML trial to start in IsraelPRICE SENSITIVE14/05/19 download Created with Sketch. 104.21KB
RAC Bisantrene IND UpdatePRICE SENSITIVE24/04/19 download Created with Sketch. 93.71KB
RAC Appendix 4C - quarterlyPRICE SENSITIVE12/04/19 download Created with Sketch. 187.25KB
RAC Race files Bisantrene IND with FDAPRICE SENSITIVE25/03/19 download Created with Sketch. 96.57KB
RAC Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE27/02/19 download Created with Sketch. 1.15MB
RAC Principal Investigator appointed for BisantrenePRICE SENSITIVE25/02/19 download Created with Sketch. 117.33KB
RAC Race Receives $228k R&D Tax Incentive RefundPRICE SENSITIVE31/01/19 download Created with Sketch. 88.33KB
RAC Appendix 4C - quarterlyPRICE SENSITIVE25/01/19 download Created with Sketch. 97.6KB
RAC Race appoints leading haematologist to support BisantrenePRICE SENSITIVE22/01/19 download Created with Sketch. 116.72KB
RAC Race signs agreement for Bisantrene NPP in IsraelPRICE SENSITIVE17/12/18 download Created with Sketch. 108.49KB
RAC Response to ASX Price QueryPRICE SENSITIVE01/11/18 download Created with Sketch. 652.83KB
RAC Race appoints Biosynergy to pursue Bisantrene licensingPRICE SENSITIVE01/11/18 download Created with Sketch. 101.31KB
RAC September 2018 Quarterly ReportPRICE SENSITIVE26/10/18 download Created with Sketch. 176.38KB
RAC Appendix 4E & Financial StatementsPRICE SENSITIVE21/08/18 download Created with Sketch. 2.52MB
RAC June 2018 Quarterly ReportPRICE SENSITIVE27/07/18 download Created with Sketch. 195.01KB
RAC FDA Grants Bisantrene Rare Paediatric Disease DesignationPRICE SENSITIVE18/07/18 download Created with Sketch. 135.44KB
RAC Trading HaltPRICE SENSITIVE16/07/18 download Created with Sketch. 523.3KB
RAC Bisantrene poster presented at French Leukaemia ConferencePRICE SENSITIVE26/06/18 download Created with Sketch. 110.77KB
RAC Bisantrene approval in UK for supply as unlicensed medicinePRICE SENSITIVE21/06/18 download Created with Sketch. 89.63KB
RAC Trading HaltPRICE SENSITIVE20/06/18 download Created with Sketch. 457.48KB
RAC RAC cancer drug success in AML reported by French doctorsPRICE SENSITIVE05/06/18 download Created with Sketch. 110.54KB
RAC Race executes agreement for Bisantrene clinical trialPRICE SENSITIVE15/05/18 download Created with Sketch. 240.94KB
RAC Appendix 4C - quarterlyPRICE SENSITIVE20/04/18 download Created with Sketch. 73.64KB
RAC Race signs global distribution agreement with Durbin PLCPRICE SENSITIVE11/04/18 download Created with Sketch. 107.1KB
RAC Race increases placement to $3.69mPRICE SENSITIVE16/03/18 download Created with Sketch. 85.57KB
RAC Race completes over-subscribed $3.159 million placementPRICE SENSITIVE12/03/18 download Created with Sketch. 107.47KB
RAC Trading HaltPRICE SENSITIVE07/03/18 download Created with Sketch. 185.36KB
RAC Second Bisantrene Patent Allowed in USPRICE SENSITIVE21/02/18 download Created with Sketch. 106.1KB
RAC Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE20/02/18 download Created with Sketch. 782.89KB
RAC Appendix 4C - quarterlyPRICE SENSITIVE31/01/18 download Created with Sketch. 93.76KB
RAC Notice of Allowance for Bisantrene Patent in USPRICE SENSITIVE29/01/18 download Created with Sketch. 107.84KB
RAC Race Receives $170k R&D Tax Incentive RefundPRICE SENSITIVE24/01/18 download Created with Sketch. 88.59KB
RAC Appendix 4C - quarterlyPRICE SENSITIVE27/10/17 download Created with Sketch. 71.55KB
RAC Race Oncology Produces First Batch of BisantrenePRICE SENSITIVE12/09/17 download Created with Sketch. 191.07KB
RAC Appendix 4E & Annual Financial StatementsPRICE SENSITIVE29/08/17 download Created with Sketch. 960.6KB
RAC Issue of OptionsPRICE SENSITIVE14/08/17 download Created with Sketch. 351.81KB
RAC Appendix 4C - quarterlyPRICE SENSITIVE26/07/17 download Created with Sketch. 50.24KB
RAC Peer-Reviewed 'The Rediscovery of Bisantrene' PublishedPRICE SENSITIVE20/07/17 download Created with Sketch. 131.46KB
RAC Race Completes Over-Subscribed $2.5 Million PlacementPRICE SENSITIVE17/07/17 download Created with Sketch. 106.6KB
RAC Trading HaltPRICE SENSITIVE13/07/17 download Created with Sketch. 362.06KB
RAC Race Joint Venture with TargImmunePRICE SENSITIVE10/07/17 download Created with Sketch. 108.69KB
RAC Trading HaltPRICE SENSITIVE07/07/17 download Created with Sketch. 365.46KB
RAC University of Wollongong R&D Collaboration
09/11/21PRICE SENSITIVE download Created with Sketch. 121.33KB
RAC Quarterly Activity Report & Appendix 4C
28/10/21PRICE SENSITIVE download Created with Sketch. 374.46KB
RAC Race secures sixth US patent for Zantrene
19/10/21PRICE SENSITIVE download Created with Sketch. 63.01KB
RAC Race secures fifth US patent for Zantrene
06/10/21PRICE SENSITIVE download Created with Sketch. 60.34KB
RAC Preclinical & Clinical Programs Update
30/09/21PRICE SENSITIVE download Created with Sketch. 71.09KB
RAC Zantrene highly effective in Melanoma preclinical study
30/09/21PRICE SENSITIVE download Created with Sketch. 827.42KB
RAC Appendix 4E & Annual Report
26/08/21PRICE SENSITIVE download Created with Sketch. 4.99MB
RAC First Patient Dosed in Phase 1b/2 AML Trial
09/08/21PRICE SENSITIVE download Created with Sketch. 117.45KB
RAC Quarterly Activity Report & Appendix 4C
29/07/21PRICE SENSITIVE download Created with Sketch. 314.92KB
RAC Race executes Israel AML Phase 2 Trial Contract
22/06/21PRICE SENSITIVE download Created with Sketch. 137.91KB
RAC Race Executes Key Contract for Israel Phase 2 AML Trial
08/06/21PRICE SENSITIVE download Created with Sketch. 59.49KB
RAC Contract to Commence Phase 2 Extramedullary AML Trial
02/06/21PRICE SENSITIVE download Created with Sketch. 122.87KB
RAC Prospectus
05/05/21PRICE SENSITIVE download Created with Sketch. 420.89KB
RAC Race investor briefing & updated presentation
05/05/21PRICE SENSITIVE download Created with Sketch. 7.51MB
RAC Placement closes oversubscribed-Bonus Option Issue launched
05/05/21PRICE SENSITIVE download Created with Sketch. 333.71KB
RAC Trading Halt
03/05/21PRICE SENSITIVE download Created with Sketch. 181.01KB
RAC Race Initiates Heart Safety Preclinical Study for Bisantrene
28/04/21PRICE SENSITIVE download Created with Sketch. 313.1KB
RAC Quarterly Activity Report & Appendix 4C
27/04/21PRICE SENSITIVE download Created with Sketch. 222.27KB
RAC Second independent study shows Bisantrene inhibits FTO
15/04/21PRICE SENSITIVE download Created with Sketch. 106.83KB
RAC Race Strategic Update March 2021
31/03/21PRICE SENSITIVE download Created with Sketch. 248.9KB
RAC Race Initiates Extramedullary AML Preclinical Study
30/03/21PRICE SENSITIVE download Created with Sketch. 112.93KB
RAC Race Initiates FTO Directed Kidney Cancer Preclinical Study
25/03/21PRICE SENSITIVE download Created with Sketch. 111.89KB
RAC Race Initiates FTO Melanoma Preclinical Study
19/03/21PRICE SENSITIVE download Created with Sketch. 114.1KB
RAC S&P DJI Announces March 2021 Quarterly Rebalance
12/03/21PRICE SENSITIVE download Created with Sketch. 183.24KB
RAC Compelling Preclinical Breast Cancer Results
09/03/21PRICE SENSITIVE download Created with Sketch. 1.27MB
RAC Appendix 4D & Half-Year Financial Statements
25/02/21PRICE SENSITIVE download Created with Sketch. 972.04KB
RAC Quarterly Activity Report & Appendix 4C
27/01/21PRICE SENSITIVE download Created with Sketch. 242.62KB
RAC Race receives $387k R&D tax incentive refund
17/12/20PRICE SENSITIVE download Created with Sketch. 100.49KB
RAC Race AGM presentations and strategic update
30/11/20PRICE SENSITIVE download Created with Sketch. 7.11MB
RAC Impressive Preclinical Bisantrene Breast Cancer Results
24/11/20PRICE SENSITIVE download Created with Sketch. 1.23MB
RAC Quarterly Activity Report & Appendix 4C
29/10/20PRICE SENSITIVE download Created with Sketch. 223.87KB
RAC Prof Borje S Andersson appointed Chief Medical Officer
02/10/20PRICE SENSITIVE download Created with Sketch. 113.33KB
RAC Race leadership team strengthened
02/09/20PRICE SENSITIVE download Created with Sketch. 118.79KB
RAC Appendix 4E & Annual Report
27/08/20PRICE SENSITIVE download Created with Sketch. 1.51MB
RAC Strategic investors make further $1.5m investment in Race
12/08/20PRICE SENSITIVE download Created with Sketch. 107.23KB
RAC Quarterly Activity Report & Appendix 4C
29/07/20PRICE SENSITIVE download Created with Sketch. 244.83KB
RAC A$3m strategic investment from prominent biotech investors
13/07/20PRICE SENSITIVE download Created with Sketch. 112.69KB
RAC Trading Halt
09/07/20PRICE SENSITIVE download Created with Sketch. 510.27KB
RAC Extension of time to repay loan through share buy-back
16/06/20PRICE SENSITIVE download Created with Sketch. 93.74KB
RAC Impressive 40% response in Phase II Bisantrene AML Trial
16/06/20PRICE SENSITIVE download Created with Sketch. 203.95KB
RAC Trading Halt
12/06/20PRICE SENSITIVE download Created with Sketch. 496.08KB
RAC Managing Director Resignation
20/05/20PRICE SENSITIVE download Created with Sketch. 120.4KB
RAC Trading Halt
18/05/20PRICE SENSITIVE download Created with Sketch. 175.55KB
RAC Pause in Trading
18/05/20PRICE SENSITIVE download Created with Sketch. 116.72KB
RAC Race starts preclinical breast cancer study for Bisantrene
14/05/20PRICE SENSITIVE download Created with Sketch. 131.29KB
RAC Quarterly Activity Report & Appendix 4C
22/04/20PRICE SENSITIVE download Created with Sketch. 165.75KB
RAC Race Secures A$1.8m strategic placement
06/03/20PRICE SENSITIVE download Created with Sketch. 107.91KB
RAC Trading Halt
04/03/20PRICE SENSITIVE download Created with Sketch. 673.25KB
RAC Appendix 4D & Half-Year Financial Statements
25/02/20PRICE SENSITIVE download Created with Sketch. 923.29KB
RAC December 2019 Quarterly Report
30/01/20PRICE SENSITIVE download Created with Sketch. 263.65KB
RAC Race Receives $159k R&D Tax Incentive Refund
16/12/19PRICE SENSITIVE download Created with Sketch. 91.29KB
RAC Race reveals new strategy for cancer drug Bisantrene
14/11/19PRICE SENSITIVE download Created with Sketch. 3.58MB
RAC Appendix 4C - quarterly
17/10/19PRICE SENSITIVE download Created with Sketch. 186.66KB
RAC Appendix 4E & Annual Report
23/08/19PRICE SENSITIVE download Created with Sketch. 1007.27KB
RAC Prominent biotech investor leads investment in Race
20/08/19PRICE SENSITIVE download Created with Sketch. 110.8KB
RAC Trading Halt
16/08/19PRICE SENSITIVE download Created with Sketch. 162.37KB
RAC Appendix 4C - quarterly
30/07/19PRICE SENSITIVE download Created with Sketch. 108.16KB
RAC First patient treated in Bisantrene trial in Israel
25/07/19PRICE SENSITIVE download Created with Sketch. 91.73KB
RAC Bisantrene AML trial to start in Israel
14/05/19PRICE SENSITIVE download Created with Sketch. 104.21KB
RAC Bisantrene IND Update
24/04/19PRICE SENSITIVE download Created with Sketch. 93.71KB
RAC Appendix 4C - quarterly
12/04/19PRICE SENSITIVE download Created with Sketch. 187.25KB
RAC Race files Bisantrene IND with FDA
25/03/19PRICE SENSITIVE download Created with Sketch. 96.57KB
RAC Appendix 4D & Half-Year Financial Statements
27/02/19PRICE SENSITIVE download Created with Sketch. 1.15MB
RAC Principal Investigator appointed for Bisantrene
25/02/19PRICE SENSITIVE download Created with Sketch. 117.33KB
RAC Race Receives $228k R&D Tax Incentive Refund
31/01/19PRICE SENSITIVE download Created with Sketch. 88.33KB
RAC Appendix 4C - quarterly
25/01/19PRICE SENSITIVE download Created with Sketch. 97.6KB
RAC Race appoints leading haematologist to support Bisantrene
22/01/19PRICE SENSITIVE download Created with Sketch. 116.72KB
RAC Race signs agreement for Bisantrene NPP in Israel
17/12/18PRICE SENSITIVE download Created with Sketch. 108.49KB
RAC Response to ASX Price Query
01/11/18PRICE SENSITIVE download Created with Sketch. 652.83KB
RAC Race appoints Biosynergy to pursue Bisantrene licensing
01/11/18PRICE SENSITIVE download Created with Sketch. 101.31KB
RAC September 2018 Quarterly Report
26/10/18PRICE SENSITIVE download Created with Sketch. 176.38KB
RAC Appendix 4E & Financial Statements
21/08/18PRICE SENSITIVE download Created with Sketch. 2.52MB
RAC June 2018 Quarterly Report
27/07/18PRICE SENSITIVE download Created with Sketch. 195.01KB
RAC FDA Grants Bisantrene Rare Paediatric Disease Designation
18/07/18PRICE SENSITIVE download Created with Sketch. 135.44KB
RAC Trading Halt
16/07/18PRICE SENSITIVE download Created with Sketch. 523.3KB
RAC Bisantrene poster presented at French Leukaemia Conference
26/06/18PRICE SENSITIVE download Created with Sketch. 110.77KB
RAC Bisantrene approval in UK for supply as unlicensed medicine
21/06/18PRICE SENSITIVE download Created with Sketch. 89.63KB
RAC Trading Halt
20/06/18PRICE SENSITIVE download Created with Sketch. 457.48KB
RAC RAC cancer drug success in AML reported by French doctors
05/06/18PRICE SENSITIVE download Created with Sketch. 110.54KB
RAC Race executes agreement for Bisantrene clinical trial
15/05/18PRICE SENSITIVE download Created with Sketch. 240.94KB
RAC Appendix 4C - quarterly
20/04/18PRICE SENSITIVE download Created with Sketch. 73.64KB
RAC Race signs global distribution agreement with Durbin PLC
11/04/18PRICE SENSITIVE download Created with Sketch. 107.1KB
RAC Race increases placement to $3.69m
16/03/18PRICE SENSITIVE download Created with Sketch. 85.57KB
RAC Race completes over-subscribed $3.159 million placement
12/03/18PRICE SENSITIVE download Created with Sketch. 107.47KB
RAC Trading Halt
07/03/18PRICE SENSITIVE download Created with Sketch. 185.36KB
RAC Second Bisantrene Patent Allowed in US
21/02/18PRICE SENSITIVE download Created with Sketch. 106.1KB
RAC Appendix 4D & Half-Year Financial Statements
20/02/18PRICE SENSITIVE download Created with Sketch. 782.89KB
RAC Appendix 4C - quarterly
31/01/18PRICE SENSITIVE download Created with Sketch. 93.76KB
RAC Notice of Allowance for Bisantrene Patent in US
29/01/18PRICE SENSITIVE download Created with Sketch. 107.84KB
RAC Race Receives $170k R&D Tax Incentive Refund
24/01/18PRICE SENSITIVE download Created with Sketch. 88.59KB
RAC Appendix 4C - quarterly
27/10/17PRICE SENSITIVE download Created with Sketch. 71.55KB
RAC Race Oncology Produces First Batch of Bisantrene
12/09/17PRICE SENSITIVE download Created with Sketch. 191.07KB
RAC Appendix 4E & Annual Financial Statements
29/08/17PRICE SENSITIVE download Created with Sketch. 960.6KB
RAC Issue of Options
14/08/17PRICE SENSITIVE download Created with Sketch. 351.81KB
RAC Appendix 4C - quarterly
26/07/17PRICE SENSITIVE download Created with Sketch. 50.24KB
RAC Peer-Reviewed 'The Rediscovery of Bisantrene' Published
20/07/17PRICE SENSITIVE download Created with Sketch. 131.46KB
RAC Race Completes Over-Subscribed $2.5 Million Placement
17/07/17PRICE SENSITIVE download Created with Sketch. 106.6KB
RAC Trading Halt
13/07/17PRICE SENSITIVE download Created with Sketch. 362.06KB
RAC Race Joint Venture with TargImmune
10/07/17PRICE SENSITIVE download Created with Sketch. 108.69KB
RAC Trading Halt
07/07/17PRICE SENSITIVE download Created with Sketch. 365.46KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$1.22
Change
-0.010(0.82%)
Mkt cap ! $212.8M
Open High Low Value Volume
$1.24 $1.25 $1.19 $177.7K 146.9K

Buyers (Bids)

No. Vol. Price($)
2 1055 $1.20
 

Sellers (Offers)

Price($) Vol. No.
$1.22 1915 1
View Market Depth
Last trade - 14.24pm 11/08/2025 (20 minute delay) ?
Last
$1.20
  Change
-0.010 ( 1.64 %)
Open High Low Volume
$1.23 $1.25 $1.20 16447
Last updated 14.10pm 11/08/2025 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.